Moderna, Inc.
$MRNA
Public valuation for Moderna, Inc. (MRNA). Fair value, signal, and key metrics — no sign-in required.
Current Price
$54.82
72% Overvalued
Fair Value Estimate
$15
📉
Distressed
Negative earnings with declining revenue
Analyst Consensus
Target: $49.37
10% lower than current
Key Metrics
Market Cap
$21.8B
Forward P/E
23.0x
Operating Margin
-356.8%
Revenue Growth
-29.0%
Get free watchlist alerts
Join the waitlist for valuation updates on $MRNA and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.